Desoxyn is Schedule II in the United States. This means it is illegal to sell without a DEA license and illegal to buy or possess without a license or prescription.

Addictive Potential: High

Emergency Room Visits Yearly: 42,538 in 2003 more...

Mandatory Minimum Sentence: Not more than 20 years in prison

Mechanism of Action: Increases the Neurotransmitters Dopamine, Norepinephine, and Serotonin

Overview:

Desoxyn® CII is a brand pharmaceutical form of methamphetamine hydrochloride (also known as desoxyephedrine, hence the name "Desoxyn"), indicated for treatment of Attention Deficit Disorder/Attention Deficit/Hyperactivity Disorder (ADD/ADHD), narcolepsy, and exogenous obesity.

Desoxyn is chemically known as (S)-N,αlpha-dimethylbenzeneethanamine hydrochloride, is a member of the amphetamine group of sympathomimetic amines.

After being first developed in the United States in 1942, Desoxyn was manufactured and marketed by Abbott Laboratories as an immediate-release tablet.

In 2002, Abbott sold their rights to Desoxyn to Ovation Pharma, which took over production and marketing of the drug (although initially, Abbott maintained production at their facilities).

Info From Ovation

Use Statistics

Full List of Childrens' Psychiatric Medications